Balentine LLC’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-272
Closed -$5K 227
2020
Q2
$5K Buy
+272
New +$4.79K ﹤0.01% 711
2018
Q4
Sell
-305
Closed -$8K 439
2018
Q3
$8K Buy
+305
New +$6.98K ﹤0.01% 193
2016
Q1
Sell
-200
Closed -$20K 335
2015
Q4
$20K Buy
+200
New +$22.5K ﹤0.01% 251
2015
Q3
Sell
-293
Closed -$65K 454
2015
Q2
$65K Buy
293
+165
+129% +$36.6K 0.01% 126
2015
Q1
$25K Buy
+128
New +$22.7K ﹤0.01% 219

Other funds holding BHC

Balentine LLC's BHC Position: Q3 2020 in Review

Balentine LLC sold out of Bausch Health (BHC) in Q3 2020, closing a stake of 272 shares — an estimated $5K sold.

Balentine LLC first reported a position in BHC in Q1 2015 and held it in 5 quarters. The position peaked at $65K in Q2 2015. 324 funds tracked by Wall St. Rank hold BHC as of Q3 2020.

  • Balentine LLC reported no remaining Bausch Health position as of Q3 2020 after selling out during the quarter.
  • Balentine LLC sold 272 Bausch Health shares in Q3 2020, an estimated $5K.
  • Balentine LLC first reported a position in Bausch Health in Q1 2015 and held it in 5 quarters.
  • Balentine LLC's Bausch Health position peaked at $65K in Q2 2015.
  • 324 funds tracked by Wall St. Rank held Bausch Health as of Q3 2020.

Based on Balentine LLC's 13F filing for Q3 2020, filed 2 Nov 2020.